Levetiracetam 1000mg Extended-Release Tablets from Canada
Extended-release tablets providing 1000mg levetiracetam for once-daily dosing in epilepsy management. This fits HTS 3004.90.92.41 as a mixed product in measured doses for retail sale, targeting central nervous system anticonvulsant therapy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide bioequivalence studies comparing to reference listed drug for ANDA products
• Label with 'extended-release' prominently to match formulation claims